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Olfactory impairment is a consistent premotor symptom in sporadic
Parkinson’s disease (PD), presumably caused by pathological
processes in the olfactory bulb and olfactory structures within
mesolimbic brain areas. The objective of the present study was to
obtain an in-depth insight into olfactory network dysfunction in PD
patients. Event-related functional magnetic resonance imaging (3 T)
was conducted with 16 early-stage PD patients and 16 matched
controls during an odor detection task. Activation within the
olfactory network was analyzed both in terms of strength of
activation (whole-brain random effects, regions of interest [ROI]
analysis based on the hemodynamic response function) as well as
time-course characteristics (finite impulse response--based ROI
analysis). Olfactory-induced activation in patients with PD in
comparison to a standard activation pattern obtained from controls
revealed profound hyperactivation in piriform and orbitofrontal
cortices. However, whereas orbitofrontal areas seem to be unable
to discriminate between signal and noise, primary olfactory cortex
shows preserved discriminatory ability. These results support
a complex network dysfunction that exceeds structural pathology
observed in the olfactory bulb and mesolimbic cortices and thus
demonstrate the important contribution of functional data to
describe network dynamics occurring in the degenerating brain.
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Introduction
A very early and consistent symptom in sporadic Parkinson’s
disease (PD) is olfactory impairment. Indeed, early involvement
of olfactory structures in the pathological process of PD is
associated with olfactory dysfunction (Braak et al. 2004; Doty
2008; Zaccai et al. 2008). Thus, the characterization of olfactory
functional brain activation may promote diagnostic sensitivity
for detecting the premotor phase of PD. However, only a few
studies have examined functional olfactory activation in PD
patients so far (Westermann et al. 2008; Welge-Lussen et al.
2009). Whereas these studies rather conducted regional
analyses on functional activation within frontostriatal loops
associated with the olfactory task, the present study aims to
investigate alterations in olfactory information processing by
analyzing local activation patterns in distinct, predeﬁned parts
of the olfactory network, using functional magnetic resonance
imaging (fMRI). More precisely, we hypothesized that the
impact of pathology on olfactory structures will be 2-fold
(Palop et al. 2006); mesolimbic olfactory brain regions that are
directly affected by degenerative processes are expected to be
impaired with respect to information processing and hence to
display hypoactivation compared with controls (Fig. 1). These
include primary (piriform cortex, entorhinal cortex, and
amygdala) as well as secondary olfactory structures (para-
hippocampal cortex and hippocampus). In contrast, non-
mesolimbic olfactory brain regions (insula and orbitofrontal
cortices [OFCs]) are assumed to show increased activation in
PD patients compared with controls, reﬂecting a compensatory
upregulation of olfactory information processing in order to
compensate network dysfunction.
Materials and Methods
Study population
Sixteen early-stage PD patients (8 women, 58.4 + 9.5 years) and 16
controls (8 women, 57.4 + 7.4 years) were recruited for the present study
(for detailed sample characteristics, see Supplementary Table s1).
Statistical analysis by means of a nonparametric Mann--Whitney U test
conﬁrmed successful matching of the 2 samples. None of the demographic
variables differed signiﬁcantly between both groups (Page = 0.616, Pgender =
1.000, Phandedness = 0.224, Pverbal intelligence = 0.239, Peducation = 0.119). None
of the subjects displayed signiﬁcant cognitive impairment as conﬁrmed by
a psychopathological screening using the Mini-Mental State Examination
(Folstein et al. 1975). Depression was excluded using the Beck Depression
Inventory (Beck et al. 1961).
Exclusion criteria leading to impaired olfactory functioning or to
structural and/or functional changes in the brain encompassed acute or
chronic disorders in the maxillary or frontal sinus (e.g., cold), allergies,
smoking, neurological disorders (except PD for the patient group),
psychiatric disorders, intake of psychoactive substances, and medica-
tion inﬂuencing olfaction. PD was diagnosed according to the guide-
lines of the German Society of Neurology that are based on the UK
Parkinson’s Disease Society Brain Bank Diagnostic Criteria for PD (Gelb
et al. 1999). Patients’ disease duration averaged 5.8 + 3.9 years, with
Uniﬁed Parkinson Disease Rating Scale part III scores (Fahn and Elton
1987) ranging from 1 to 11.5/56 (mean score: 8 + 3.9) and Hoehn and
Yahr stages ranging from I (n = 6), I--II (n = 2), and II (n = 8) (Hoehn
and Yahr 2001). With regard to the affected side, the majority displayed
right-sided parkinsonism, with only 4 patients being more affected on
the left side. Symptoms could be classiﬁed as tremor-dominant in 7
patients, as akinetic-rigid in 6 patients, and as equivalent in 3 patients.
All but one patient were treated with dopaminergic drugs. Equivalence
dose rates ranged from 150 to 800 mg, with an average dose of 416 mg
(standard deviation = 223.7 mg). The study protocol was approved by
the institutional review board and conducted according to the Code of
Ethical Principles for Medical Research involving human subjects of the
World Medical Association (Declaration of Helsinki). All subjects gave
written informed consent.
Psychophysical Assessment of Olfactory Function
Olfactory performance was quantitatively assessed using 3 subtests
(sensitivity, identiﬁcation, and discrimination) of the Snifﬁn’ Sticks test
(Burghardt medical technology) (Kobal et al. 1996). Individual scores of
each subtest ranging from 0 (minimal performance) to 16 (maximal
performance) were entered into a Mann--Whitney U test for statistical
analysis of group differences. A composite TDI (Threshold, Discrimi-
nation, Identiﬁcation) score representing the sum of results obtained
by threshold, discrimination, and identiﬁcation is used to classify
olfactory performance, with TDI scores <29 indicating hyposmia,
Besides conﬁrming olfactory impairment in PD patients, olfactory tests
were used to exclude olfactory dysfunction in controls (also as
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a putative premotor symptom of PD), as well as to conﬁrm remaining
ability to discern olfactory stimuli in PD patients.
Odorants and Olfactometry
Olfactory stimuli were presented bilaterally using air-dilution olfac-
tometry. During scanning, subjects wore a common nasal cannula
(Airlife, CardinalHealth) consisting of a plastic tube that ﬁts behind the
ears, and a pair of prongs that are placed in the nostrils (Ø 2 mm).
Besides the advantage of a precise and standardized presentation of the
odorants, the nasal cannula minimizes the tendency of the subjects to
actively sniff because the airﬂow is already directed into the nasal
cavity.
The following odorants (Sigma-Aldrich) were used at suprathreshold
concentration (%): amylacetate (banana, 0.015), ethylbutanol (pineap-
ple, 0.003), and lavender oil (lavender, 0.008). These odorants, which
were not identical to any odor used in the Snifﬁn’ Sticks test, have been
shown to be predominantly olfactory (Savic et al. 2000; Anderson et al.
2003; Cerf-Ducastel and Murphy 2003). Analysis does not distinguish
between the 3 odorants that were used to minimize the effect of
desensitization due to adaptation.
Experimental fMRI Design
During the scanning session, subjects were engaged in an odor
detection task, which required the differentiation between odor events
and blank events (Fig. 2A). Thirty-six odor and 36 blank trials were
presented in a pseudorandomized order, with each trial lasting 28 s.
Trials were composed of the following phases: baseline (10 s),
preparation (2 s), event (10 s), and response (6 s). Subjects were
informed about the current phase by the color of a centrally presented
ﬁxation cross. As event phases were separated for at least 18 s, sensory
adaptation was minimized. During the response phase, perception of
odor in the event phase was indicated via button press, allowing an
indirect rating of the subject’s olfactory sensitivity in terms of signal
detection theory (see below). Before starting the fMRI experiment,
subjects were trained to breathe normally and regularly without
snifﬁng.
Imaging Parameters
MR data were obtained with a 3-T Allegra Magnetom (Siemens)
equipped with a standard, single-channel, full-head receive coil. A total
of 1009 volumes were collected using a T2* sensitive echo-planar
sequence (echo time [TE]: 30 ms, repetition time [TR]: 2 s, ﬂip angle:
90, voxel size: 3 3 3 3 3 mm3, ﬁeld of view [FOV]: 192 mm, number of
slices: 34, slice thickness: 3 mm, slice distance: 0.3 mm, and slice
acquisition sequence: interleaved). Slices were oriented slightly oblique
to the anterior--posterior commissure plane traversing from frontal pole
to temporal pole. After functional data acquisition, a full-brain T1-
weighted 3D image was generated as magnetization-prepared rapid
gradient echo (TE: 2.6 ms, TR: 22.50 ms, voxel size: 1 3 1 3 1 mm3, FOV:
256 mm, and slice thickness: 1 mm).
Behavioral Data Analysis
The button press during MR scanning served as a stimulus-response
template for each subject, which could be compared with the actual
event of the respective trial. The experiment can therefore be regarded
as a typical signal detection situation, which requires a yes--no decision
in a noisy environment (Wickens 2002). Trials without olfactory
stimulation, that is, blank trials, correspond to noise trials, whereas
Figure 1. Schematic overview of brain activation in controls (left) and PD patients (right). The physiological network, which is illustrated in the left diagram, was defined on the
basis of olfactory-induced brain activation in controls. Olfactory sensory input arrives from the olfactory bulb in primary olfactory structures and is further projected to higher
ordered structures (bottom-up processing). The olfactory network is modulated by different neurotransmitters (e.g., dopamine) both at primary and higher order level (top-down
modulation). Structures shown on dark background represent core regions of the olfactory network, which emerged exclusively in response to odorant presentation. These include
all primary as well as several higher order olfactory structures, most of which are situated in the mesolimbic part of the brain. In contrast, structures shown on bright background,
that is, insula and OFC, seem to be target of top-down modulation, as these structures showed significant increase in activation during non-odor events as well. The diseased
network in PD patients is shown on the right. Increased size of the boxes indicates hyperactivation. Dashed lines represent a loss of signal--noise discrimination. The degradation
of the arrows reflects a hypothesized dysfunction in signal transmission, both bottom-up (projections within the olfactory network, in particular mesolimbic) and top-down
(dopaminergic projections of the brain stem). 1: Piriform and entorhinal cortex, 2: amygdala, 3: parahippocampal cortex, 4: hippocampus, 5: insula, and 6: OFC. OB: olfactory bulb,
VTA: ventral tegmental area, SN: substantia nigra.
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trials with olfactory stimulation are called signal (plus noise) trials,
referring to the fact that additional information, namely the signal, is
superimposed upon the noise. For each subject, the following variables
were determined: hit rate h (i.e., ratio of number of hits to number of
signal trials), false-alarm rate f (i.e., ratio of number of false alarms to
number of noise trials), and sensitivity d’. Parameter estimation for d’
was based on the equal-variance Gaussian model, allowing its value to
be calculated from h and f :
dˆ# =Z

h

– Z

f

:
The parameter d’ indicates the distance between both noise and
signal distributions for each subject. The smaller d’, the smaller is
the distance, and the more difﬁcult is the discrimination of signal
from noise. This parameter therefore approximates the sensitivity
of a person. If the value of d’ is near 0, the signal cannot be
discriminated from noise because both distributions overlap. De-
tectability increases with increasing d’, resulting in a spatial
separation of both distributions.
Functional Image Analysis
Image Processing, SPM{T } Extraction, and Contrast Deﬁnition
Imaging data were analyzed using SPM5 (Statistical Parametric Mapping,
Welcome Trust Centre for Neuroimaging, London, UK). Subsequent to
standard spatial preprocessing procedures, including realignment,
coregistration, spatial normalization into standard anatomical Montreal
Neurological Institute (MNI) space, and smoothing with an 8-mm (full-
width half-maximum) Gaussian kernel (Friston et al. 1995), data
underwent statistical analysis based on the general linear model. In
order to account for transient effects, for example, adaptation
(Poellinger et al. 2001), the event phase was split into 2 halves. We
were therefore able to model functional activation for the entire 10-s
event phase, as well as for the ﬁrst and the following 5 s of an event. In
addition, the response phase was included into the design matrix,
resulting in an implicit baseline, which coincides with the baseline
phase of the trial. Based on this design matrix, 3 types of contrasts were
deﬁned. In ‘‘stimulation-speciﬁc contrasts,’’ activation during odor
events was directly compared with activation during blank events
(‘‘odor vs. blank’’). In ‘‘event-speciﬁc contrasts,’’ activation during event
phases was compared with baseline (‘‘odor vs. baseline,’’ ‘‘blank vs.
baseline’’). Both stimulation- and event-speciﬁc contrasts were analyzed
for the entire length of the event, as well as for the ﬁrst half of the
event. Finally, a contrast was computed to selectively assess sensory
adaptation, which has been widely documented for primary olfactory
areas to occur within 10--30 s after stimulus presentation (Wilson 1998;
Sobel et al. 2000; Poellinger et al. 2001; Best and Wilson 2004). Sensory
adaptation, also referred to as central habituation, is characterized by
a transient increase followed by a prolonged decrease in activation that
even falls below baseline level. To optimally model this time course,
a ‘‘time course--speciﬁc contrast’’ was computed that compares the ﬁrst
half of the event to the second half of each trial (‘‘odor1 vs. odor2,’’
‘‘blank1 vs. blank2’’).
Experimental Deﬁnition of the Olfactory Network
Given the expected variability of the patient sample due to limited
accuracy of clinical diagnostic criteria, the olfactory network was
deﬁned for subsequent analysis in 2 complementary ways.
As a ﬁrst approach, activation in controls obtained by random effects
analysis was used to deﬁne a standard activation pattern that was
compared with functional activation in PD patients. This approach
allowed for a network deﬁnition without being guided by a priori
hypotheses. Network deﬁnition was conducted based on selectivity
patterns of functional activation revealed by the contrasts described
above, according to the following rationale: brain regions responding
exclusively to one kind of event (i.e., either odor or blank) were
classiﬁed as ‘‘selective,’’ and brain regions reacting to both event types
as ‘‘unselective.’’ Brain regions selective for odor events can thus be
assigned to the olfactory network, which is engaged in bottom-up
processing of odorant information. In contrast, selective brain regions
in blank trials appear to be involved in top-down modulation, for
example, attention and motivation.
In a second approach, several structurally deﬁned regions of interest
(ROI) were selected a priori to approximate the classical olfactory
network as reported previously (Savic 2002) to be analyzed in each
subject. ROIs were selected from the MNI-based aal database (Tzourio-
Mazoyer et al. 2002) implemented in the SPM toolbox MarsBaR (http://
marsbar.sourceforge.net) for each hemisphere. Mesolimbic olfactory
structures encompass the piriform cortex, amygdala, parahippocampal
cortex, and hippocampus. Non-mesolimbic olfactory projection sites
include the insula and OFC. To account for functional heterogeneity
within the OFC, analysis differentiates among 4 orbitofrontal zones, that
is, inferior, superior, medial, and middle OFC. See Supplementary Table
s5 for selected ROIs.
Statistical Analysis
1. A voxel-by-voxel analysis was made in terms of whole-brain random
effects analysis based on the hemodynamic response function (HRF),
both within and between groups, to reveal signiﬁcant effects of
olfactory stimulation without being guided by a priori hypotheses.
As clinical populations are generally expected to display a higher
heterogeneity in functional activation, group SPM{T}s were thresh-
olded at a more liberal level of Puncorr <0.0001. Only voxels
belonging to clusters that surpassed a threshold of Pcorr <0.05 on
cluster level were considered as activated.
2. ROI were analyzed according to 2 different statistical approaches. In
order to determine differences in strength of olfactory-induced
activation in a priori deﬁned areas, effects of interest were extracted
based on a convolution of b parameter estimates with the canonical
HRF. Subsequently, mean scores of activation in response to
different experimental conditions were calculated for each ROI
using the contrasts outlined above. Between-group comparison was
conducted on these contrast estimates, and results were reported as
being signiﬁcant at a threshold of Puncorr <0.05 according to
nonparametric Mann--Whitney U statistics.
3. In a second approach, time courses of activation based on an
alternative model speciﬁcation (the ﬁnite impulse response [FIR]
function) were estimated for each ROI and each experimental
condition. Signiﬁcant differences between time courses during odor
and blank events indicate the ability of an ROI to discriminate
between signal and noise. For this purpose, a mean value as the best
representative of a data set was calculated for a time segment, which
comprised time points 2--5 after stimulus onset and therefore
corresponded to the event phase (seconds 14--20) of the trial. To
reveal signiﬁcant differences in FIR time courses in odor and blank
trials within each group, individual mean values of the time segment
obtained during odor and blank trials were entered into a Wilcoxon
test (Puncorr < 0.05).
Results
Behavioral data
Statistical analysis of Snifﬁn’ Sticks scores revealed signiﬁcantly
better performance in controls as compared with PD patients
in all 3 subtests of threshold (Z = 3.274, Pcorr = 0.003),
discrimination (Z = 2.822, Pcorr = 0.012), and identiﬁcation (Z =
3.916, Pcorr < 0.001). The mean TDI score in controls was
therefore higher and within the normosmic range (mean TDI:
30 + 6, min: 21, max: 37), in contrast to the mean TDI value in
PD patients, that showed reduced olfactory function (mean
TDI: 19 + 6; min: 13, max: 27). With regard to behavioral
performance during scanning, that is, button presses in
response to odorant detection, controls were signiﬁcantly
better in identifying olfactory stimuli, that is, signals (h : Z =
3.783, Puncorr = 0.001), although all PD patients were able to
detect all 3 odorants in a test trial before scanning. In contrast,
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false alarms were not signiﬁcantly different between both
groups (f : Z = 1.568, Puncorr = 0.119). Overall signal-noise
discrimination (i.e., sensitivity, d’) was signiﬁcantly better in
controls (d’: Z = 3.186, Puncorr = 0.001).
fMRI Data
Random Effects Analysis
Selectivity classiﬁcation of activation in controls was used to
deﬁne a standard activation pattern that was compared with
functional activation in PD patients (Fig. 2B,C and Table 1; for
detailed information, see Supplementary Table s2).
Using our paradigm, activated brain regions in controls,
which exclusively responded to odor events, correspond to
primary olfactory structures (Sobel et al. 2000; Savic 2002)
(Fig. 2B). No primary olfactory brain region was active on blank
trials. Selective activation in secondary olfactory brain struc-
tures was observed in the hippocampus bilaterally, left puta-
men, and pallidum, as well as left middle and inferior OFC
(Brodmann area [BA] 10). Among these olfactory brain regions,
habituation, partly with activation falling under baseline level,
Figure 2. Altered brain activation in PD patients (random effects analysis). (A) Depiction of the experimental time course. Each trial consisted of a baseline, event, and response
phase. The only difference between blank and odor trials was the presence or absence of the odorant during event phase. (B and C) Statistical parametric maps showing significant
brain activation (Pcorr\ 0.05, SPM{T} threshold: Puncorr\ 0.0001) in controls during odor and blank events, revealed by event-specific contrasts (i.e., comparison of the first half of
the event to baseline, ‘‘event1 vs. baseline’’) and time course--specific contrasts (i.e., comparison of the first half of the event to the second half of the same event, ‘‘event1 vs.
event2’’). Depicted activation refers to cross-hair position. (B) Significant activation in controls. ‘‘Odor1 vs. baseline’’: right piriform cortex and amygdala (left; MNI: 26, 4, 18), right
insula (middle; MNI: 34, 24, 6), left OFC (right; MNI: 44, 42, 4). ‘‘Odor1 vs. odor2’’: left piriform cortex, amygdala, and superior temporal pole (left; MNI: 38, 6, 12), right
amygdala (30, 6, 18), and right hippocampus (right; MNI: 40, 32, 12). ‘‘Blank1 vs. baseline’’: left insula (MNI: 38, 16, 2). ‘‘Blank1 vs. blank2’’: left rolandic operculum and
superior temporal gyrus (MNI:58, 0, 2). (C) Significant activation in PD patients. ‘‘Odor1 vs. baseline’’: right piriform cortex and amygdala (left, MNI: 20,1,20), left inferior OFC
and insula (middle, MNI: 38, 22, 4), and right superior OFC (right, MNI: 20, 54, 10). ‘‘Odor1 vs. odor2’’: right parahippocampal cortex and amygdala (left, MNI: 18, 1, 18),
left amygdala, temporal pole, and middle temporal gyrus (middle, MNI: 20, 1, 18), left hippocampus and thalamus (right, MNI: 20, 34, 2). ‘‘Blank1 vs. baseline’’: left
amygdala (MNI: 21, 0, 18). ‘‘Blank1 vs. blank2’’: left piriform cortex, amygdala, and hippocampus (MNI: 17, 3, 18).
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could be observed in the piriform cortex, parahippocampal
cortex, and in the hippocampus, as revealed by the time--
course--speciﬁc contrast. In contrast, unselective activation
during both odor and blank events was displayed in the insula
bilaterally and in the right middle and inferior OFC (BA 11).
In PD patients, the difﬁculty to discern between olfactory
stimuli is reﬂected in the reduced selectivity of brain activation
in response to olfactory stimulation. Only the left piriform
cortex (part of the primary olfactory cortex) and insula (part of
the secondary olfactory cortex) showed selective activation in
odor trials, while the remaining primary and secondary
olfactory structures displayed a signiﬁcant, unselective increase
in activation (e.g., amygdala, hippocampus, parahippocampal,
and OFC, Fig. 2C). In addition, those brain regions that were
selective for blank events in controls were also activated during
odor events in PD patients, that is, amygdala, hippocampus, and
left OFC.
Direct between-group comparison was statistically too
restrictive to obtain signiﬁcant results, which can also be
attributed to susceptibility artifacts in mesial brain regions,
and to activation differences between both groups, which are
not pronounced enough to survive statistical whole-brain
correction.
ROI Analysis
Differences in activation strength. When directly comparing
functional activation between controls and PD patients in pre-
deﬁned ROIs, statistically signiﬁcant differences can be found in
the piriform cortex as the main part of the primary olfactory
cortex and in orbitofrontal areas due to hyperactivation in PD
patients (see Supplementary Table s3 and Fig. s1). No hyper-
activation was observed in the remaining parts of the olfactory
network, that is, amygdala, insula, hippocampus, and para-
hippocampal cortex.
In accordance with results obtained by random effects
analysis indicating a loss of selectivity of the olfactory network,
hyperactivation of the piriform and OFC was observed during
both odor and blank trials. However, a closer look on the
hyperactivation of the piriform cortex revealed signiﬁcantly
different levels of activation during odor and blank trials,
suggesting preserved selectivity to odor trials despite a general
increase of activation (Fig. 3). This question is further explored
using FIR-based analysis of time courses.
Differences in activation time course. When FIR time courses
of odor (i.e., signal) trials were compared with those of blank
(i.e., noise) trials, between-group comparison revealed reduced
discriminatory ability in PD patients, thereby conﬁrming the
loss of selectivity as well as the behavioral results obtained in
signal detection analysis (see Supplementary Tables s4 and s5).
Signal-noise discrimination was evident in only 6 ROIs in PD
patients, whereas controls showed selectivity for olfactory
stimulation in 9 ROIs. This difference is mainly due to a lack of
signal-to-noise discrimination in orbitofrontal regions, which
ﬁts the results obtained by HRF-based ROI analysis indicating
hyperactivation. Interestingly, the hyperactivated piriform
cortex sustains discriminatory ability, thereby conﬁrming the
ﬁndings of both random effects and HRF-based ROI analysis.
Detailed comparison of both groups reveals a loss of selectivity
in the left amygdala (Fig. 4A,B), right hippocampus (Fig. 4C,D),
and in the OFC bilaterally in PD patients.
Discussion
In the present study, we could identify signiﬁcant alterations
within the olfactory network in PD (Fig. 1), including hyper-
activation and reduced signal-noise discrimination. Alterations
could be found at various levels of the cerebral olfactory
Table 1
Significant brain activation in controls and PD patients during odor and blank (i.e., non-odor)
events as revealed by random effects, classified according to selectivity
Odor trials Blank trials
Controls
Selective Unselective Selective
Piriform (R)
Amygdala (L, R)
Parahippocampal (R)
Hippocampus (L, R)
Superior temporal pole (L, R)
Putamen (L)
Pallidum (L)
Middle OFC (L)
Inferior OFC (L)
Insula (L, R)
Precuneus (L)
Postcentral gyrus (L)
Middle OFC (R)
Inferior OFC (R)
Rolandic operculum (L, R)
Superior temporal gyrus (L, R)
Middle temporal gyrus (L)
Cuneus (L, R)
Middle cingulate gyrus (R)
Superior frontal gyrus (R)
Inferior frontal operculum (L)
PD patients
Selective Unselective Selective
Piriform (L)
Pallidum (L)
Insula (L)
Middle temporal gyrus (R)
Superior temporal gyrus (L, R)
Amygdala (L)
Parahippocampal (L, R)
Hippocampus (L)
Superior temporal pole (L, R)
Insula (R)
Middle OFC (L, R)
Inferior OFC (L, R)
Anterior cingulate gyrus (R)
Putamen (L, R)
Precuneus (L, R)
Postcentral gyrus (L, R)
Rolandic operculum (L)
Inferior frontal operculum (L, R)
Middle temporal gyrus (L)
Note: Brain activation revealed by the 3 HRF-based contrast estimations (i.e., stimulation-specific,
event-specific, and time course--specific contrast) was classified in terms of selectivity, thereby
allowing a characterization of altered activation patterns in PD as compared with the activation
pattern shown by controls (i.e., standard activation pattern). For detailed information, see
Supplementary Table s2. L5 left and R 5 right.
Figure 3. Preserved olfactory discrimination in the hyperactivated piriform cortex in
PD (ROI analysis). When comparing odor events to blank events, signal--noise
discrimination as shown in controls (full bars) persists in PD patients (striped bars).
However, a general hyperactivation to both events can be found in PD patients. Mean
percent signal change þ standard error (averaged over time bins 2--5, i.e., seconds
2--10) of the left and right piriform cortex (PIR) in controls and PD patients (PD) during
odor and blank events, with **Puncorr \ 0.01, *Puncorr \ 0.05, according to
nonparametric Wilcoxon statistic.
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system, as revealed by both random effects and ROI analysis,
which are 2 complementary approaches chosen to obtain
a detailed picture of functional olfactory activation in PD.
Importantly, the piriform cortex, which is considered as the
major part of the primary olfactory cortex receiving direct
input from the olfactory bulb, displays pronounced hyper-
activation in PD patients, but at the same time is signiﬁcantly
modulated by the presence of olfactory stimulation. This sets it
apart from higher order structures of the olfactory network
that have lost their ability to distinguish signal from noise and
bears important implications with regard to the role of early
and pronounced pathological affection of the bulb hypothet-
ically causing olfactory deﬁcits in PD.
Hyperactivation at All Levels of the Olfactory System
Contrary to our original hypothesis of a degeneration-induced
hypoactivation in directly affected mesolimbic olfactory struc-
tures, this study provides evidence for a profound hyper-
activation of the olfactory network. At best, the only hint for
PD-related hypoactivation is the reduced recruitment of right-
hemispheric olfactory brain regions, which was indicated in
the statistically restrictive whole-brain random effects analysis.
Likewise, a previous study reported unilateral, left-sided
activation of the amygdala and hippocampus comparing
whole-brain random effects between controls and patients
(Westermann et al. 2008). However, whereas this study
focused on dopaminergic modulated brain regions related to
corticostriatal loops, we further explored regions representing
core units of the olfactory system, thereby revealing profound
hyperactivation in both left and right hemispheric olfactory
centers. This implies that PD-related pathology, at least in early
stages of the disease, does not lead to a reduction in neuronal
activity in directly affected brain regions, but rather has an
opposite effect on activation level. A follow-up study did not
report increased, but rather decreased activation in primary
and secondary olfactory structures for patients with disturbed
olfactory event-related potentials (OERPs) (Welge-Lussen et al.
2009) suggesting that reduced integrity of signal transmission
as reﬂected by OERPs (Lotsch and Hummel 2006) is associated
with advanced neurodegeneration. Combining these ﬁndings
with the results of the present study, a complex pattern of
olfactory network dysregulation in PD emerges, presumably
including both bottom-up and top-down processes. These may
relate to 1) disrupted signal transmission as a direct effect of
neurodegeneration within early olfactory structures, 2) alter-
ations in modulation of neuroplasticity within olfactory in-
formation processing, and 3) disease stage-dependent changes
in dysregulation patterns. Intriguingly, hyperactivation in PD
patients has also been reported in response to motor stimuli
(for reviews, see Dagher and Nagano-Saito 2007), within core
regions of the motor network such as sensorimotor cortices
(Sabatini et al. 2000; Haslinger et al. 2001; Muller et al. 2003; Yu
et al. 2007), as well as in functionally related motor networks
(Samuel et al. 1997; Catalan et al. 1999; Haslinger et al. 2001).
These changes in activation might result not only directly from
detrimental disinhibition due to dopamine deﬁciency, which
presumably relates to speciﬁc motor symptoms such as rigidity
and bradykinesia (Kleine et al. 2001; Pierantozzi et al. 2001)
but also from compensatory upregulation (Sabatini et al.
2000; Ceballos-Baumann 2003). Although the present data
cannot be directly compared with results obtained in these
studies, similar considerations could be addressed for the
olfactory network as well. Thus, neurodegeneration-based loss
of signal transmission and/or compensatory mechanisms might
contribute to hyperactivation associated with olfactory dys-
function. Considering the ﬁnding that hyperactivation seems to
be limited to the initial input stage of the cerebral olfactory
network, namely the piriform cortex and the OFC that can be
Figure 4. Loss of signal--noise discrimination in the olfactory network in PD (ROI analysis). (A and C) FIR time courses during odor and blank trials (mean percent signal change of
each single time bin ± standard error [SE]) in controls (left) and PD patients (right) in the left amygdala (A) and right hippocampus (C). The highlighted area represents the event
phase (seconds 2--10 after stimulus onset, i.e., odor presentation) of the trial. The axis of ordinates is depicted in seconds. (B and D) Mean percent signal change ± SE, averaged
over time bins 2--5, that is, seconds 2--10, in the left amygdala (B) and right hippocampus (D), with **Puncorr\ 0.01, *Puncorr\ 0.05, according to nonparametric Wilcoxon
statistic.
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seen as an higher order convergence zone of top-down and
bottom-up processes, we propose that the network’s core unit
(primary olfactory structures) displays dysfunctional disinhibi-
tion due to early pathology and/or dopaminergic depletion,
which subsequently leads to compensatory activation in
functionally related, higher order units of the network.
Preserved Olfactory Discrimination in the Piriform
Cortex in PD
All statistical approaches, in particular ROI analysis based on
the FIR function, revealed a profound loss of signal--noise
discrimination in the olfactory system of PD patients. However,
while secondary structures, including amygdala, hippocampus,
and orbitofrontal areas lost their ability to discriminate signal
from noise (Fig. 1), the piriform cortex in the hyposmic PD
patients is still able to isolate olfactory input. Thus, the crucial
loss of information during olfactory signal propagation leading
to hyposmia in PD patients is not only limited to impaired signal
propagation by the olfactory bulb and tract. Extensive
pathology affecting both neurites (Lewy neurites) and neuronal
cell bodies (Lewy bodies) is found in the olfactory bulb and
anterior olfactory nucleus in early PD (Braak et al. 2002), which
is accompanied by a substantial increase in dopaminergic
inhibitory interneurons in the olfactory bulb (Huisman et al.
2004, 2008), and disrupted olfactory tract ﬁbers (Scherﬂer et al.
2006). These studies suggest that loss of signal input is caused
by structural alterations in the olfactory bulb and tract. Further
evidence of atrophy in olfactory brain regions links impaired
sensory processing to structural decline (Wattendorf et al.
2009). Thus, neurodegeneration-mediated disinhibition might
cause hyperactivation. However, in light of the present
functional data and recent neuropathological ﬁnding describing
heterogeneous pathological affection of the piriform cortex
(Silveira-Moriyama et al. 2009), hyperactivation of the piriform
cortex seems to indicate the distortion of olfactory information
when being propagated to higher order units of the olfactory
network. However, the persistent ability of the primary
olfactory cortex to discriminate between signal and noise
supports the hypothesis that olfactory impairment in PD is not
only limited to loss of signal input from pathologically affected
olfactory bulb and tract, but functional impairment of the
entire olfactory system is relevant for hyposmia in PD.
Having characterized distinct activation patterns within the
olfactory network in PD in this study, the question regarding its
speciﬁcity compared with other hyposmic patients has to be
addressed in further research. To date, only few studies have
investigated functional activation to odors in hyposmia of
different etiologies (congenital hyposmia, Henkin and Levy
2002, Alzheimer’s disease, Wang et al. 2010, and various
etiologies other than neurologic/psychiatric, Levy et al.
1998). To our knowledge, none of these studies has reported
hyperactivation in response to olfactory stimulation. In
contrast, volumetric analysis of MR data has revealed reduced
gray matter volume in a wide range of hyposmics, for example,
in PD (Wattendorf et al. 2009), Alzheimer’s disease (Thomann
et al. 2009), genetic aberrations (Blustajn et al. 2008), and
posttraumatic hyposmia (Collet et al. 2009; Bitter et al. 2010).
Thus, future comparative analyses are required to determine
PD-speciﬁc structural and functional alterations associated with
hyposmia.
The present study offers new insights into neural plasticity
within disturbed functional networks in early PD in order to
restore performance. The observed hyperactivation suggests
compensatory upregulation of neural activity at all levels of
olfactory information processing. However, the observed loss
of signal-to-noise discrimination in mesolimbic olfactory
structures, which appears to be spread to higher-order regions
of the olfactory network, indicates the failure of this
compensatory attempt. Moreover, we propose that impairment
of olfactory network function is a dynamic process during the
course of PD, which might be used to identify different stages
of the disease process in PD. Our ﬁndings extend the
knowledge of altered activation patterns of the olfactory
system in PD patients (Fig. 1). In conjunction with previous
approaches to correlate olfactory dysfunction in at-risk
populations of PD (Ponsen et al. 2004; Sommer et al. 2004;
Stiasny-Kolster et al. 2005), our results with respect to changes
in the neural circuitry associated with PD underline the
importance of understanding olfactory dysfunction to provide
ground for establishing additional diagnostic tools for early
premotor PD.
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